Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapyBeth L. Thurberg, M. W. O'CALLAGHAN, Helmut G. Rennke et al.|Kidney International|2002Cited by 331
Fabry Disease: Preclinical Studies Demonstrate the Effectiveness of α-Galactosidase A Replacement in Enzyme-Deficient MiceYiannis A. Ioannou, Robert J. Desnick, Ken M. Zeidner et al.|The American Journal of Human Genetics|2001Cited by 201
NPC1 late endosomes contain elevated levels of non-esterified (‘free’) fatty acids and an abnormally glycosylated form of the NPC2 proteinFannie W. Chen, Yiannis A. Ioannou, Ronald E. Gordon|Biochemical Journal|2005Cited by 54
LIM-Nebulette Reinforces Podocyte Structural Integrity by Linking Actin and Vimentin FilamentsXuhua Ge, Evren U. Azeloglu, Nanditha Anandakrishnan et al.|Journal of the American Society of Nephrology|2020Cited by 40
KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progressionKristin Meliambro, Kirk N. Campbell, Yanfeng Yang et al.|JCI Insight|2023Cited by 9